SEC Form 4 · accession 0001209191-15-039432
SYNAPTICS Inc · SYNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Deutsch
Officer — SVP of Sales
Period of report
May 4, 2015
Accepted (ET)
May 6, 2015 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000817720
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 4, 2015 | M | 1,622 | $35.76 | A | 8,330 | D | |
| Common Stock | May 4, 2015 | M | 328 | $46.50 | A | 8,658 | D | |
| Common Stock | May 4, 2015 | M | 1,637 | $60.22 | A | 10,295 | D | |
| Common Stock | May 4, 2015 | M | 1,310 | $61.40 | A | 11,605 | D | |
| Common Stock | May 4, 2015 | M | 679 | $62.105 | A | 12,284 | D | |
| Common Stock | May 4, 2015 | M | 982 | $78.11 | A | 13,266 | D | |
| Common StockF2 | May 4, 2015 | S | 2,295 | $84.8959 | D | 10,971 | D | |
| Common StockF3 | May 4, 2015 | S | 5,303 | $85.7551 | D | 5,668 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F4 | $35.76 | May 4, 2015 | M | 1,622 | D | — | Jan 28, 2020 | Common Stock | 1,622 | 12,501 | D |
| Employee Stock Option (Right to Buy)F5 | $46.50 | May 4, 2015 | M | 328 | D | — | Oct 28, 2020 | Common Stock | 328 | 1,965 | D |
| Employee Stock Option (Right to Buy)F6 | $60.22 | May 4, 2015 | M | 1,637 | D | — | Jan 27, 2021 | Common Stock | 1,637 | 2,294 | D |
| Employee Stock Option (Right to Buy)F7 | $61.40 | May 4, 2015 | M | 1,310 | D | — | Apr 28, 2021 | Common Stock | 1,310 | 2,620 | D |
| Employee Stock Option (Right to Buy)F8 | $62.105 | May 4, 2015 | M | 679 | D | — | Oct 24, 2021 | Common Stock | 679 | 3,396 | D |
| Employee Stock Option (Right to Buy)F9 | $78.11 | May 4, 2015 | M | 982 | D | — | Aug 1, 2021 | Common Stock | 982 | 2,949 | D |
Explanation of responses
- F1The shares were sold pursuant to a 10b5-1 Sales Plan dated February 20, 2015.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.39 to $85.29, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.43 to $86.03, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4One-third of the total number of shares subject to the option vested and became exercisable on the 12-month anniversary of the January 28, 2013 grant date, and 1/36th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 28th day of each month thereafter until fully vested on January 28, 2016.
- F51/12th of the total number of shares subject to the options vested or shall vest and became or shall become exercisable each quarter following the October 28, 2013 grant date until fully vested on October 28, 2016.
- F61/12th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable each quarter following the January 27, 2014 date of grant until fully vested on January 27, 2017.
- F71/12th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable each quarter following the April 28, 2014 date of grant until fully vested on April 28, 2017.
- F81/12th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable each quarter following the October 24, 2014 date of grant until fully vested on October 24, 2017.
- F91/12th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable each quarter following the August 1, 2014 date of grant until fully vested on August 1, 2017.